Pharma News

A study  led by Columbia obstetricians has shown that a new intrauterine device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in real-world situations.

An LSU Health New Orleans research study led by Siqiong June Liu, PhD, Professor of Cell Biology and Anatomy, has found that cerebellar inhibitory interneurons are essential for fear memory, a type of emotional memory formation. Inhibitory interneurons within the cerebellar circuitry act as gatekeepers and control the output of the cerebellar cortex. The formation of fear memory requires the activity of these interneurons.

Through study findings published Friday in Cell Reports, a team of scientists at VCU Massey Cancer Center discovered a previously unknown interaction between proteins that is responsible for supplying energy to tumor cells and could hold significant implications for the development of future treatments for colon cancer.

New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that depression and the risk of depression are linked to different inflammatory proteins in boys and girls.

When inflammation occurs in the body a host of proteins are released into the blood called cytokines. Previous research has shown that higher levels of cytokines are associated with depression in adults, but little is known about this relationship in adolescence.

Eminence Business Media's third edition of the Cleaning Validation program, which took place at Radisson Blu, Mumbai International Airport on August 24th and 25th, 2023, offered a fresh approach to addressing critical cleaning validation bottleneck issues. This program was meticulously crafted to provide the attendees with an engaging and solution-oriented experience, aiming to resolve industry pain points and impart valuable insights.

IIHMR University, Jaipur, hosted TEDxIIHMRU, an event that brought together changemakers and visionaries passionate about driving positive change. The theme – Inspire, Innovate, Impact – called for challenging the status quo and making a real difference. Dr. P.R. Sodani, President of IIHMR University, inaugurated the program by lighting a lamp and welcoming the distinguished speakers. Mr. Punnet Datta, CEO, IIHMR Foundation coordinated the event.

'Hygiene and Health'' is a pressing issue, especially in countries like India. The main objective of Swachhata Pakhawada programme is to spread information and awareness about hygiene and health to the vulnerable community with the help of the young generation. Moreover, this programme emphasizes a series of standard and professional activities like Campaigns and Capacity Building Workshops, to build health awareness and encourage hygiene practices. At the primary stage, IIHMR University is engaging students to organize awareness campaigns.

AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in China for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least one prior therapy.